Clinical trial
A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction With Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer
NCT02122185 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Placebo Controlled Phase II Trial of Metformin in Conjunction With Chemotherapy Followed by Metformin Maintenance Therapy in Advanced Stage Ovarian, Fallopian Tube and Primary Peritoneal Cancer
- Lead sponsor
- University of Chicago
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 25, 2015
- Completion date
- October 8, 2024
- Enrollment
- 111 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.
brenner tumor, malignant ascites, malignant pleural effusion, ovarian clear cell cystadenocarcinoma, ovarian endometrioid adenocarcinoma, ovarian mixed epithelial carcinoma, ovarian serous cystadenocarcinoma, ovarian undifferentiated adenocarcinoma, recurrent fallopian tube cancer, recurrent ovarian epithelial cancer, recurrent ovarian germ cell tumor, recurrent primary peritoneal cavity cancer, stage iiia fallopian tube cancer, stage iiia ovarian epithelial cancer, stage iiia ovarian germ cell tumor, stage iiia primary peritoneal cavity cancer, stage iiib fallopian tube cancer, stage iiib ovarian epithelial cancer, stage iiib ovarian germ cell tumor, stage iiib primary peritoneal cavity cancer, stage iiic fallopian tube cancer, stage iiic ovarian epithelial cancer, stage iiic ovarian germ cell tumor, stage iiic primary peritoneal cavity cancer, stage iv fallopian tube cancer, stage iv ovarian epithelial cancer, stage iv ovarian germ cell tumor, stage iv primary peritoneal cavity cancer